CliffBio
small molecule

CUPRIMINE

PENICILLAMINE

Loss of exclusivity—loss of exclusivity
CompanyVALEANT PHARMACEUTICALS INTERNATIONAL

Drug detail

Brand nameCUPRIMINE
Active ingredientPENICILLAMINE
Strength125MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from VALEANT PHARMACEUTICALS INTERNATIONAL

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CUPRIMINE patent cliff — loss of exclusivity — | CliffBio